Page last updated: 2024-10-30

metformin and Cancer Pain

metformin has been researched along with Cancer Pain in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.

Research Excerpts

ExcerptRelevanceReference
"However, the function of aspirin use in pancreatic cancer largely remains unknown."2.53Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. ( Dai, JJ; Gu, DN; Huang, Q; Jiang, MJ; Tian, L, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, MJ1
Dai, JJ1
Gu, DN1
Huang, Q1
Tian, L1

Reviews

1 review available for metformin and Cancer Pain

ArticleYear
Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials.
    Biochimica et biophysica acta, 2016, Volume: 1866, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Aspirin; Cancer Pain; Humans; Metformin; Pancreatic Neoplasms

2016